Accendra HealthACH -0.87%57 Buyback Yield % is 3.28 as of Jul. 01, 2026, which is 104% above its 10-year median of 1.61. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 40 Medical Distribution companies, Accendra Health ranks better than 77.5% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Accendra Health's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Accendra Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Accendra Health's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a Buyback Yield % of 3.28 as of Jul. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Accendra Health and its competitors. This is 104% above median its historical median of 1.61. According to the industry distribution chart, Accendra Health ranks #9 out of 40 companies in the Medical Distribution industry, placing it in the top 22.5%.
Is Accendra Health's Buyback Yield % too high?
Accendra Health's current Buyback Yield % of 3.28 is 104% above median its 10-year median of 1.61. The Medical Distribution industry median Buyback Yield % is 0.02. Accendra Health's value of 3.28 is 16300% above this industry median. Based on the distribution chart, Accendra Health ranks #9 out of 40 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Buyback Yield % compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #9 out of 40 companies for Buyback Yield %. This places Accendra Health in the top 23% of its industry — outperforming the majority of peers. The industry median Buyback Yield % is 0.02. Accendra Health's value of 3.28 is 16300% above this benchmark. While the company's 10-year median is 1.61 vs. the industry median of 0.02, Accendra Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
The median Buyback Yield % among Medical Distribution companies is 0.02, based on 40 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current Buyback Yield % of 3.28 is 16300% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median Buyback Yield % is 0.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current Buyback Yield % is 3.28, which is 104% above median its own 10-year median of 1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.42 — trading 31.9% below its estimated fair value. The current Buyback Yield % is 3.28, which is 104% above median its 10-year median of 1.61 and 16300% above the Medical Distribution industry median of 0.02. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Accendra Health (ACH), the current Buyback Yield % is 3.28 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.42 is trading 31.9% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
Buyback Yield %: 3.28 (104% above median its 10-year median of 1.61)
GF Value™: $5.02 vs. price of $3.42 (31.9% below fair value)
Industry Position: 16300% above the Medical Distribution median (#9 of 40)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score
Get the complete analysis for ACH
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
